Literature DB >> 10839928

Isoflurane alters the recirculatory pharmacokinetics of physiologic markers.

M J Avram1, T C Krejcie, C U Niemann, C Enders-Klein, C A Shanks, T K Henthorn.   

Abstract

BACKGROUND: Earlier studies have demonstrated that physiologic marker blood concentrations in the first minutes after administration, when intravenous anesthetics exert their maximum effect, are determined by both cardiac output and its distribution. Given the reported vasodilating properties of isoflurane, we studied the effects of isoflurane anesthesia on marker disposition as another paradigm of altered cardiac output and regional blood flow distribution.
METHODS: The dispositions of markers of intravascular space and blood flow (indocyanine green), extracellular space and free water diffusion (inulin), and total body water and tissue perfusion (antipyrine) were determined in four purpose-bred coonhounds. The dogs were studied while awake and while anesthetized with 1.7%, 2.6%, and 3.5% isoflurane (1.15, 1.7, and 2.3 minimum alveolar concentration, respectively) in a randomized order determined by a Latin square experimental design. Marker dispositions were described by recirculatory pharmacokinetic models based on very frequent early, and less frequent later, arterial blood samples. These models characterize the role of cardiac output and regional blood flow distribution on drug disposition.
RESULTS: Isoflurane caused a significant and dose-dependent decrease in cardiac output. Antipyrine disposition was profoundly affected by isoflurane anesthesia, during which nondistributive blood flow was maintained despite decreases in cardiac output, and the balance between fast and slow tissue volumes and blood flows was altered.
CONCLUSIONS: The isoflurane-induced changes in marker disposition were different than those the authors reported previously for halothane anesthesia, volume loading, or hypovolemia. These data provide further evidence that not only cardiac output but also its peripheral distribution affect early drug concentration history after rapid intravenous administration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839928     DOI: 10.1097/00000542-200006000-00036

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats.

Authors:  Sandrine Marchand; Claire Dahyot; Isabelle Lamarche; Olivier Mimoz; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 2.  Clinically important drug interactions with intravenous anaesthetics in older patients.

Authors:  Helge Eilers; Claus Niemann
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

3.  Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission.

Authors:  Marleen Keyaerts; Jacob Verschueren; Tomas J Bos; Lea Olive Tchouate-Gainkam; Cindy Peleman; Karine Breckpot; Chris Vanhove; Vicky Caveliers; Axel Bossuyt; Tony Lahoutte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-04       Impact factor: 9.236

4.  Constant Rate Infusion of Lidocaine, Tumescent Anesthesia and Their Combination in Dogs Undergoing Unilateral Mastectomy.

Authors:  Cecilia Vullo; Adolfo Maria Tambella; Annastella Falcone; Gabriele Marino; Giuseppe Catone
Journal:  Animals (Basel)       Date:  2021-04-29       Impact factor: 2.752

5.  Cardiopulmonary Effects and Pharmacokinetics of Dexmedetomidine Used as an Adjunctive Analgesic to Regional Anesthesia of the Oral Cavity with Levobupivacaine in Dogs.

Authors:  Matic Pavlica; Mojca Kržan; Ana Nemec; Tina Kosjek; Anže Baš; Alenka Seliškar
Journal:  Animals (Basel)       Date:  2022-05-09       Impact factor: 2.752

6.  Influence of sevoflurane anesthesia with mechanical ventilation and fluid-therapy on distribution of subcutaneously administered robenacoxib in dogs.

Authors:  Norihiko Oyama; Tadashi Sano; Mizuki Yamamori; Jun Tamura; Mohammed Ahmed Umar; Yusuke Endo; Yusyun Ishikawa; Akifumi Itoh; Kenjirou Miyoshi; Kazuto Yamashita
Journal:  J Vet Med Sci       Date:  2018-08-03       Impact factor: 1.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.